Beetroot Red Food Color Gets Temporary Government Timeout
Published Date: 3/24/2026
Rule
Summary
The FDA is hitting the pause button on the new rule that lets food makers use beetroot red as a color in most foods. This delay happens because some folks raised concerns, so the FDA needs more time to review before making it official. No money changes yet, but food companies and consumers will have to wait a bit longer for this colorful update.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
Beetroot Red Use Delayed for Food Makers
As of March 20, 2026, the FDA has delayed indefinitely the February 6, 2026 final order that would have allowed food makers to use beetroot red (added as 21 CFR 73.39) for coloring human foods generally. The delay was triggered by timely objections (including a submission dated March 5, 2026) and legally prevents the final order from taking effect until FDA resolves those objections or announces a new effective date.
Consumers Face Delay in Beetroot Red Foods
You will not see foods newly colored with beetroot red under the February 6, 2026 final order while the FDA has delayed the order as of March 20, 2026. The delay is indefinite and will remain in place until FDA publishes a document announcing a new effective date or other administrative action.
FDA Safety Finding Remains Intact
The FDA says its scientific determination that there is a "reasonable certainty of no harm" from beetroot red under the proposed conditions of use has not changed, even though the effective date of the rule is delayed as of March 20, 2026. FDA also says it will address the filed objections in a future document.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13047 — Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-13346 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medication Guides for Prescription Drug Products
The FDA is updating how it collects info about Medication Guides—those important leaflets that come with some prescription drugs to keep patients safe. This affects drug makers who must follow new rules about what info to include and how to share it. Comments on these changes are open until July 31, 2026, and the update aims to keep patients informed without adding extra costs.
2026-13140 — Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of Oxygenation
The FDA is officially putting the monitor for opioid-induced oxygen problems into a safer, easier-to-manage category called Class II. This change helps make sure the device works well and is safe, while also speeding up patient access to this important tech. The new rules took effect on June 30, 2026, and could lower costs and delays for companies making these monitors.
2026-13139 — Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of Hyperhidrosis
The FDA is officially classifying the skin patch that treats excessive sweating (hyperhidrosis) as a Class II device, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps patients get access to this cool new treatment faster and safer, starting June 30, 2026. Companies making these patches will find it easier and less costly to bring their products to market.
2026-13006 — Determination of Regulatory Review Period for Purposes of Patent Extension; VYALEV
The FDA has officially set the review period for the drug VYALEV, which helps the company extend its patent protection. This means the patent clock can be paused, giving the drug maker more time to sell VYALEV exclusively. If anyone thinks the dates are wrong or the company wasn’t diligent, they can speak up by late 2026.
2026-13005 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; New Animal Drugs for Minor Use and Minor Species
The FDA is asking for public feedback on their plan to keep collecting info about new animal drugs for rare uses and less common species. This affects drug makers who want special approval and incentives for these unique animal medicines. Comments are open until July 29, 2026, and the process helps keep these important drugs safe and available without extra costs.
Previous / Next Documents
Previous: 2026-05731 — Establishment of the Nine Lakes of East Tennessee Viticultural Area
Starting April 23, 2026, the Nine Lakes of East Tennessee becomes an official wine region, covering over 4,000 square miles in northeastern Tennessee. This new American Viticultural Area (AVA) helps local winemakers proudly label their wines with a unique origin, making it easier for wine lovers to find and enjoy wines from this special spot. No extra costs or changes for consumers, just a fresh new name on the wine map!
Next: 2026-05733 — Listing of Color Additive Exempt From Certification; Spirulina Extract; Delay of Effective Date
The FDA is hitting the pause button on the new rules about using spirulina extract as a food color. This delay affects food makers who were ready to use spirulina more widely but now have to wait because some folks asked for a review. No safety worries yet, but the new rules won’t kick in until the FDA sorts things out, so no changes or costs happen just yet.